Logo image of MN

Manning and Napier Inc (MN) Stock Fundamental Analysis

NYSE:MN - New York Stock Exchange, Inc. - US56382Q1022 - Common Stock - Currency: USD

12.85  +0.02 (+0.16%)

After market: 12.85 0 (0%)

Fundamental Rating

3

MN gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 225 industry peers in the Capital Markets industry. MN scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. MN is not valued too expensively and it also shows a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

MN had positive earnings in the past year.
MN had a positive operating cash flow in the past year.
MN Yearly Net Income VS EBIT VS OCF VS FCFMN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 20M 40M 60M 80M 100M

1.2 Ratios

Industry RankSector Rank
ROA 10.93%
ROE 18.53%
ROIC 20.44%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
MN Yearly ROA, ROE, ROICMN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 10 20 30 40 50

1.3 Margins

MN's Profit Margin has improved in the last couple of years.
MN's Operating Margin has declined in the last couple of years.
Industry RankSector Rank
OM 20.57%
PM (TTM) 12.07%
GM N/A
OM growth 3Y14.76%
OM growth 5Y-16.89%
PM growth 3Y98.7%
PM growth 5Y21.97%
GM growth 3YN/A
GM growth 5YN/A
MN Yearly Profit, Operating, Gross MarginsMN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 10 20 30 40

More info and screens

5

2. Health

2.1 Basic Checks

The number of shares outstanding for MN has been increased compared to 1 year ago.
Compared to 1 year ago, MN has an improved debt to assets ratio.
MN Yearly Shares OutstandingMN Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 5M 10M 15M
MN Yearly Total Debt VS Total AssetsMN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 50M 100M 150M 200M

2.2 Solvency

An Altman-Z score of 4.33 indicates that MN is not in any danger for bankruptcy at the moment.
MN has a debt to FCF ratio of 0.00. This is a very positive value and a sign of high solvency as it would only need 0.00 years to pay back of all of its debts.
MN has a Debt/Equity ratio of 0.00. This is a healthy value indicating a solid balance between debt and equity.
Although MN does not score too well on debt/equity it has very limited outstanding debt, which is well covered by the FCF. We will not put too much weight on the debt/equity number as it may be because of low equity, which could be a consequence of a share buyback program for instance. This needs to be investigated.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 4.33
ROIC/WACCN/A
WACCN/A
MN Yearly LT Debt VS Equity VS FCFMN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 50M 100M 150M

2.3 Liquidity

A Current Ratio of 2.96 indicates that MN has no problem at all paying its short term obligations.
A Quick Ratio of 2.96 indicates that MN has no problem at all paying its short term obligations.
Industry RankSector Rank
Current Ratio 2.96
Quick Ratio 2.96
MN Yearly Current Assets VS Current LiabilitesMN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 50M 100M 150M

More info and screens

4

3. Growth

3.1 Past

MN shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -13.25%.
The Earnings Per Share has been growing by 12.71% on average over the past years. This is quite good.
MN shows a small growth in Revenue. In the last year, the Revenue has grown by 6.49%.
Measured over the past years, MN shows a very negative growth in Revenue. The Revenue has been decreasing by -10.17% on average per year.
EPS 1Y (TTM)-13.25%
EPS 3Y75.83%
EPS 5Y12.71%
EPS Q2Q%-64.52%
Revenue 1Y (TTM)6.49%
Revenue growth 3Y-3.36%
Revenue growth 5Y-10.17%
Sales Q2Q%-6.32%

3.2 Future

MN is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 288.83% yearly.
Based on estimates for the next years, MN will show a small growth in Revenue. The Revenue will grow by 5.68% on average per year.
EPS Next Y1411.86%
EPS Next 2Y288.83%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year19.61%
Revenue Next 2Y5.68%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
MN Yearly Revenue VS EstimatesMN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 100M 200M 300M 400M
MN Yearly EPS VS EstimatesMN Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 0.2 0.4 0.6 0.8 1

More info and screens

4

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 15.67, MN is valued correctly.
The average S&P500 Price/Earnings ratio is at 29.63. MN is valued slightly cheaper when compared to this.
With a Price/Forward Earnings ratio of 14.40, MN is valued correctly.
MN's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 22.68.
Industry RankSector Rank
PE 15.67
Fwd PE 14.4
MN Price Earnings VS Forward Price EarningsMN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Industry RankSector Rank
P/FCF 9.1
EV/EBITDA 4.33
MN Per share dataMN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6

4.3 Compensation for Growth

MN's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as MN's earnings are expected to grow with 288.83% in the coming years.
PEG (NY)0.01
PEG (5Y)1.23
EPS Next 2Y288.83%
EPS Next 3YN/A

More info and screens

3

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 1.58%, MN has a reasonable but not impressive dividend return.
Compared to the average S&P500 Dividend Yield of 2.27, MN is paying slightly less dividend.
Industry RankSector Rank
Dividend Yield 1.58%

5.2 History

The dividend of MN decreases each year by -32.14%.
MN has been paying a dividend for at least 10 years, so it has a reliable track record.
Dividend Growth(5Y)-32.14%
Div Incr YearsN/A
Div Non Decr YearsN/A
MN Yearly Dividends per shareMN Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 0.2 0.4 0.6

5.3 Sustainability

21.52% of the earnings are spent on dividend by MN. This is a low number and sustainable payout ratio.
DP21.52%
EPS Next 2Y288.83%
EPS Next 3YN/A
MN Yearly Income VS Free CF VS DividendMN Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 20M 40M 60M 80M 100M
MN Dividend Payout.MN Dividend Payout, showing the Payout Ratio.MN Dividend Payout.PayoutRetained Earnings

More info and screens

Manning and Napier Inc

NYSE:MN (10/20/2022, 8:04:00 PM)

After market: 12.85 0 (0%)

12.85

+0.02 (+0.16%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryCapital Markets
Earnings (Last)08-09 2022-08-09/amc
Earnings (Next)11-08 2022-11-08/amc
Inst Owners2.09%
Inst Owner Change0%
Ins Owners5.79%
Ins Owner Change0%
Market Cap245.75M
Analysts37.78
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 1.58%
Yearly Dividend0.1
Dividend Growth(5Y)-32.14%
DP21.52%
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 15.67
Fwd PE 14.4
P/S 1.7
P/FCF 9.1
P/OCF 8.87
P/B 2.61
P/tB 2.75
EV/EBITDA 4.33
EPS(TTM)0.82
EY6.38%
EPS(NY)0.89
Fwd EY6.95%
FCF(TTM)1.41
FCFY10.98%
OCF(TTM)1.45
OCFY11.27%
SpS7.57
BVpS4.93
TBVpS4.68
PEG (NY)0.01
PEG (5Y)1.23
Profitability
Industry RankSector Rank
ROA 10.93%
ROE 18.53%
ROCE N/A
ROIC 20.44%
ROICexc N/A
ROICexgc 21.31%
OM 20.57%
PM (TTM) 12.07%
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3Y28.34%
ROICexcg growth 5Y-10.38%
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y14.76%
OM growth 5Y-16.89%
PM growth 3Y98.7%
PM growth 5Y21.97%
GM growth 3YN/A
GM growth 5YN/A
F-Score7
Asset Turnover0.91
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA N/A
Cap/Depr 14.92%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality 154.51%
Current Ratio 2.96
Quick Ratio 2.96
Altman-Z 4.33
F-Score7
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)31.44%
Cap/Depr(5y)57.95%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)396.73%
Profit Quality(5y)673.59%
High Growth Momentum
Growth
EPS 1Y (TTM)-13.25%
EPS 3Y75.83%
EPS 5Y12.71%
EPS Q2Q%-64.52%
EPS Next Y1411.86%
EPS Next 2Y288.83%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)6.49%
Revenue growth 3Y-3.36%
Revenue growth 5Y-10.17%
Sales Q2Q%-6.32%
Revenue Next Year19.61%
Revenue Next 2Y5.68%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y145.38%
FCF growth 3Y14.18%
FCF growth 5Y-19.11%
OCF growth 1Y119.83%
OCF growth 3Y11.17%
OCF growth 5Y-18.97%